About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Microvascular Coronary Artery Disease: Review Article

Citation:

US Cardiology Review 2018;12(1):41–5.

Clinical Trial Perspective: Optimizing Crossover From Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome (CAPITAL OPTICROSS)

Citation:

US Cardiology Review 2017;11(2):59–61.

Performing and Interpreting Fractional Flow Reserve Measurements in Clinical Practice: An Expert Consensus Document

Citation:

Interventional Cardiology Review 2017;12(2):97–109

Novel Pharmacologic Treatments for Cardiovascular Disease: A Practical Update

Citation:

US Cardiology Review 2017;11(2):98–104.